← Eichor
Study identifier: NCT06346158 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prediction of Propofol Effect-Site Concentration Associated With Deep Anesthesia

Condition: Anesthesia  ·  Sponsor: Ciusss de L'Est de l'Île de Montréal

PhaseN/A
Planned participants110
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to explore the variability of the concentration at the effect site (Ce) of propofol to reach deep anesthesia (DA) during induction of general anesthesia in adults. The investigators hypothesized that there is a great variability in this Ce that could be precisely explained by * Electroencephalographic (EEG) features available prior to induction of anesthesia * Cognitive performance * Patients characteristics Participants will undergo preoperative cognitive testing and awake EEG. Then, induction of general anesthesia will be performed using continuous infusion of propofol. The Ce at which Deep anesthesia is observed will be recorded.

This description comes directly from the study's public registry record.

Talk to the study team

Louis Morisson, MD, MSc  ·  514-252-3400  ·  louis.morisson@umontreal.ca

Nadia Godin, RN  ·  514-252-3400  ·  nadia.godin.hmr@ssss.gouv.qc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Hopital Maisonneuve-RosemontMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06346158